9 results
Conversion - Epoetin alfa (Procrit®) to Darbepoetin alfa (Aranesp™)

#Epoetin #Darbepoetin #Erythropoietin #Conversion #Table #ESAs #Procrit #Aranesp
Erythropoietin #Conversion #Table ... Procrit #Aranesp #Pharmacology ... #Hematology #Nephrology
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
MithuRheum #rheumatology ... management #autoimmune #pharmacology ... #table
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #medications #table ... decisionaid #cardiology #hematology
Systemic Sclerosis (Scleroderma)
Multi-system autoimmune disease characterized by vasculopathy and progressive fibrosis of skin and internal organs
3
distal to elbows/wrists ... Scleroderma #SSc #rheumatology ... symptoms #testing #workup
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
• Immunologic Workup ... • Immunologic Workup ... sle #comparison #table ... #rheumatology #
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
Chemotherapy #Oncology #Hematology ... #Interactions #Table ... #Pharmacology
REBEL Review 90: Weight Based 4 Factor PCC Dosing 

#Hematology #Management #Table #4FactorPCC #REBELReview #Pharmacology #Dosing
PCC Dosing #Hematology ... #Management #Table ... #REBELReview #Pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Otherwise, it works ... drug to remain stable ... semaglutide #Diabetes #Pharmacology
Taken from Dr Motov's work on a CERTA regime.
This is published in conjunction with the CERTA
from Dr Motov's work ... #Management #Pharmacology ... PainSyndromes #Pathways #Table